Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook

Sonic Healthcare booked 8% FY25 sales growth, reaffirmed its FY26 outlook, and completed a major acquisition.

Key points
  • Sonic Healthcare reported an 8% rise in both statutory revenue to A$9,645 million and EBITDA to A$1,725 million for FY2025, alongside a 6% EPS increase to 106.7 cents.
  • The company confirmed FY26 EBITDA guidance of A$1.87–1.95 billion, supported by acquisitions like LADR Laboratory Group in Germany and strong revenue growth.
  • Looking forward, Sonic plans to maintain organic growth, focus on cost control and EPS enhancement, and continue its progressive dividend strategy amid recent market underperformance.

The Sonic Healthcare Ltd (ASX: SHL) share price is in focus after the company reaffirmed its FY26 earnings guidance and posted 8% revenue and EBITDA growth for FY2025.

A group of people in a corporate setting do a collective high five.

Image source: Getty Images

What did Sonic Healthcare report in FY25?

  • Statutory revenue for FY2025 rose 8% year-over-year to A$9,645 million
  • EBITDA increased by 8% to A$1,725 million
  • Net profit climbed 7% to A$514 million
  • Earnings per share improved by 6% to 106.7 cents
  • Total FY2025 dividends of $1.07 per share, up 1% on the prior year
  • Cash generated from operations jumped 21% to A$1,297 million

What else do investors need to know?

Sonic Healthcare confirmed its FY26 EBITDA guidance range of A$1.87–1.95 billion (on constant currency), targeting up to 13% growth on FY25. Year-to-date statutory revenue as of October 2025 grew 17%, with organic revenue up 5%, supported by recent acquisitions and contract wins.

The company completed the acquisition of LADR Laboratory Group in Germany, marking a significant milestone. This deal, partly funded by issuing new Sonic shares, is expected to deliver immediate earnings per share accretion and strong returns after synergies.

What's next for Sonic Healthcare?

Looking ahead, Sonic Healthcare expects first-half weighting for FY2026 earnings to follow historical patterns, after an atypical FY2025. The company plans to sustain organic growth through innovation in pathology and diagnostics as well as pursue further targeted acquisitions.

Management is focused on controlling costs, boosting earnings per share, and extracting value from recent acquisitions, while maintaining a progressive dividend policy supported by ongoing strong cash flows.

Sonic Healthcare share price snapshot

Over the past 12 months, Sonic shares have fallen 23%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on ASX Share Market News

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild, but ultimately positive, Tuesday for investors.

Read more »

Red percentage sign in front of a chart.
ASX Share Market News

ASX 200 slips as RBA boosts interest rates to 15-year highs

ASX investors and mortgage holders are now eyeing the highest interest rates in 15 years.

Read more »

Rocket going up above mountains, symbolising a record high.
Share Gainers

Invested $5,000 in Dateline shares a week ago? Here's how much you'd have now

It's been a huge week for Dateline shares.

Read more »

two cute young boys dressed in business suits sit amid a pile of papers with a calculator and adding machine looking very happy for themselves.
Broker Notes

Buy, hold, sell: Fortescue, Westpac, CSL shares

One of these ASX shares is forecast to climb another 9% over the next 12 months.

Read more »

Woman working on her laptop at a café.
Broker Notes

Buy, hold, sell: Woodside, Life360, Ramsay Health Care shares

New stock tips for investors this week.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Buy, hold, sell: Corporate Travel Management, JB Hi-Fi, BHP shares

Here's what the experts think.

Read more »

ASX board.
ASX Share Market News

ASX 200 holds steady as investors brace for a big afternoon

Investors are preparing for a key decision today.

Read more »

Four miners discussing with each other next to mining machinery.
Broker Notes

This ASX iron ore junior could rise more than 33% UBS says

This company's high grade product is in demand, the broker argues.

Read more »